AstraZeneca Signs $330 Million Deal with Johnson & Johnson Affiliate
October 07 2016 - 3:00AM
Dow Jones News
LONDON--AstraZeneca PLC (AZN.LN) said Friday has sold its rights
outside the U.S. for nasal spray Rhincourt Aqua to Johnson &
Johnson (JNJ) affiliate Cilag GmbH International for $330
million.
The British drugs company said the deal should be finalized by
the end of this year.
Write to Olga Cotaga at olga.cotaga@wsj.com, Twitter
@OlgaCotaga
(END) Dow Jones Newswires
October 07, 2016 02:45 ET (06:45 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024